Literature DB >> 6765249

On the genesis and regulation of cellular heterogeneity in malignant tumors.

G Poste, R Greig.   

Abstract

The growing body of evidence showing that malignant tumors are heterogeneous and contain diverse subpopulations of cells with different metastatic abilities is reviewed. The factors that may influence the evolution of cellular diversity at different stages in the progression of malignant neoplasms are discussed. Particular emphasis is given to the possibility that interactions occurring between the constituent subpopulations of a malignant tumor may influence the rate at which new variant subpopulations emerge. Metastatic heterogeneity poses significant problems for experimental efforts to identify the cellular features that correlate with metastatic behavior and for the therapy of metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6765249

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  30 in total

Review 1.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

2.  DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Stan A Lightfoot; Aimee B Hoskins; Megan Lerner; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Altaf Mohammed; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

3.  Pulmonary tumor colony formation following i.v. inoculation of six human colorectal carcinoma xenografts in young gnotobiotic athymic mice.

Authors:  R J Zimmerman; E T Gaillard; A Goldin
Journal:  Clin Exp Metastasis       Date:  1988 Jan-Feb       Impact factor: 5.150

Review 4.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

5.  Dynamic heterogeneity: experimental metastasis studies with RIF-1 fibrosarcoma.

Authors:  B M Korycka; R P Hill
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

6.  Targeted drug delivery to tumors: myths, reality and possibility.

Authors:  You Han Bae; Kinam Park
Journal:  J Control Release       Date:  2011-06-06       Impact factor: 9.776

Review 7.  Quantitative genetic analysis of tumor progression.

Authors:  V Ling; A F Chambers; J F Harris; R P Hill
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.

Authors:  Xiaochun Zhang; Ritsuko Komaki; Li Wang; Bingliang Fang; Joe Y Chang
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

9.  Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.

Authors:  Rifat Hasina; Mark E Whipple; Leslie E Martin; Winston Patrick Kuo; Lucila Ohno-Machado; Mark W Lingen
Journal:  Lab Invest       Date:  2008-02-18       Impact factor: 5.662

10.  Metastatic phenotype of human prostate tumor cells in athymic nude mice: alteration by exposure to ethyl methanesulfonate and "reversion" by 5-azacytidine.

Authors:  J L Ware; A P Lieberman; K S Webb
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.